CLASSICAL HODGKIN LYMPHOMA
Clinical trials for CLASSICAL HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSICAL HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSICAL HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for young hodgkin patients: drug combo aims to cut radiation
Disease control Recruiting nowThis study tests a new treatment for children, teens, and young adults (ages 2 to 34) with newly diagnosed classical Hodgkin lymphoma. The drug brentuximab vedotin replaces two older drugs in the standard chemo mix, with the goal of achieving a faster complete response on PET sca…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated May 26, 2026 06:02 UTC
-
New hope for kids with tough cancers: immunotherapy drug shows promise
Disease control Recruiting nowThis study tests a drug called pembrolizumab in children aged 6 months to 18 years with advanced melanoma, solid tumors, or lymphoma that has spread, come back, or not responded to treatment. The drug helps the immune system fight cancer. The goal is to see if it can shrink or el…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 05:50 UTC
-
New hope for tough blood cancers: experimental drug MGD024 enters human testing
Disease control Recruiting nowThis early-stage trial tests a new drug called MGD024 in people with certain blood cancers (like leukemia and lymphoma) that came back or didn't get better with standard treatments. The main goal is to find a safe dose and understand side effects. About 130 adults will receive th…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated May 26, 2026 05:44 UTC
-
Lifestyle plan aims to boost Well-Being in lymphoma survivors
Symptom relief Recruiting nowThis study tests whether a personalized healthy lifestyle plan can improve quality of life for people who have survived certain types of lymphoma (Hodgkin lymphoma, DLBCL, or PMBCL). Participants must be between 18 and 50 years old and in remission for 3 to 10 years. The study wi…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: NA • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC
-
Blood test may predict hodgkin lymphoma relapse in kids
Knowledge-focused Recruiting nowThis study is exploring whether a blood test that detects tumor DNA (called ctDNA) can help predict if Hodgkin lymphoma will come back in children and young adults under 25. Researchers will follow 400 participants over several years to see if ctDNA levels at diagnosis and during…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC